GENERALIZED MYASTHENIA GRAVIS
Clinical trials for GENERALIZED MYASTHENIA GRAVIS explained in plain language.
Never miss a new study
Get alerted when new GENERALIZED MYASTHENIA GRAVIS trials appear
Sign up with your email to follow new studies for GENERALIZED MYASTHENIA GRAVIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to ease muscle weakness in myasthenia gravis patients
Disease control OngoingThis study tests two experimental drugs, pozelimab and cemdisiran, alone or together, in 288 adults with generalized myasthenia gravis, a disease causing muscle weakness and fatigue. The goal is to see if these drugs improve daily activities and muscle strength. Participants must…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 09:03 UTC
-
New drug trial aims to ease rare Muscle-Weakening disease in kids
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called rozanolixizumab in children aged 2 and older with generalized myasthenia gravis, a condition that causes muscle weakness. Participants will receive additional 6-week treatment cycles. The goal is to monitor serious side ef…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 17, 2026 09:01 UTC
-
New drug shows promise for muscle weakness in myasthenia gravis
Disease control OngoingThis study tests a new drug called ALXN1720 in adults with generalized myasthenia gravis (gMG), a condition that causes muscle weakness. The goal is to see if the drug improves daily activities and muscle strength compared to a placebo. About 261 participants with specific antibo…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 17, 2026 08:48 UTC
-
New hope for rare muscle disease: drug trial targets patients standard treatments miss
Disease control OngoingThis study tests an investigational drug called efgartigimod in adults with generalized myasthenia gravis (gMG) who do not have the typical acetylcholine receptor antibodies. The trial compares the drug to a placebo to see if it improves daily activities and muscle strength. Abou…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
New hope for myasthenia gravis: Long-Term drug trial underway
Disease control OngoingThis study looks at the long-term safety and effectiveness of the drug zilucoplan for people with generalized myasthenia gravis, a chronic muscle weakness condition. About 200 participants who completed a prior zilucoplan study will receive the drug openly. The goal is to see if …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New hope for kids with rare muscle disease: zilucoplan safety trial launches
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a daily injection called zilucoplan in children with a rare autoimmune disease that causes muscle weakness. Up to 8 children who completed a previous study will receive the drug for another 52 weeks. The goal is to monitor side effects …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: UCB Biopharma SRL • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New drug shows promise for rare Muscle-Weakening disease
Disease control OngoingThis study tests a drug called batoclimab in 240 adults with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see if it can improve daily activities and muscle strength better than a placebo. Participants receive injections weekly or every tw…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Immunovant Sciences GmbH • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
New hope for kids with rare Muscle-Weakening disease
Disease control OngoingThis study tests a drug called ravulizumab in children aged 6 to 18 with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see how the drug works in the body and if it helps control symptoms. Twelve participants will receive the drug through a…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New drug tested for long-term safety in kids with rare muscle weakness disease
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of a drug called efgartigimod in children with generalized myasthenia gravis, a disease that causes muscle weakness. About 12 children who already took part in earlier studies will continue receiving the drug either through a vein or as a …
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase: PHASE2, PHASE3 • Sponsor: argenx • Aim: Disease control
Last updated Apr 26, 2026 20:02 UTC